CID 66571003

Zandelisib

Structural Information

Molecular Formula
C31H38F2N8O
SMILES
CC(C)(CC1=CC=CC=C1C2CCN(CC2)C)NC3=NC(=NC(=N3)N4CCOCC4)N5C6=CC=CC=C6N=C5C(F)F
InChI
InChI=1S/C31H38F2N8O/c1-31(2,20-22-8-4-5-9-23(22)21-12-14-39(3)15-13-21)38-28-35-29(40-16-18-42-19-17-40)37-30(36-28)41-25-11-7-6-10-24(25)34-27(41)26(32)33/h4-11,21,26H,12-20H2,1-3H3,(H,35,36,37,38)
InChIKey
WPFUFWIHMYZXSF-UHFFFAOYSA-N
Compound name
4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[2-methyl-1-[2-(1-methylpiperidin-4-yl)phenyl]propan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine
Related CIDs

2D Structure

compound 2d structure
4
Annotation Hits

4
References

1060
Patents

576.31366 Da
Monoisotopic Mass

5.7
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 577.32094 243.0
[M+Na]+ 599.30288 246.2
[M-H]- 575.30638 247.1
[M+NH4]+ 594.34748 236.6
[M+K]+ 615.27682 236.7
[M+H-H2O]+ 559.31092 224.4
[M+HCOO]- 621.31186 243.8
[M+CH3COO]- 635.32751 243.9
[M+Na-2H]- 597.28833 238.7
[M]+ 576.31311 236.1
[M]- 576.31421 236.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe